Clearside Biomedical Inc (CLSD)
1.32
+0.05
(+3.94%)
USD |
NASDAQ |
May 02, 16:00
1.30
-0.02
(-1.52%)
After-Hours: 20:00
Clearside Biomedical Revenue (TTM): 8.226M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.226M |
| September 30, 2023 | 2.211M |
| June 30, 2023 | 1.618M |
| March 31, 2023 | 0.984M |
| December 31, 2022 | 1.327M |
| September 30, 2022 | 26.68M |
| June 30, 2022 | 29.49M |
| March 31, 2022 | 29.89M |
| December 31, 2021 | 29.58M |
| September 30, 2021 | 3.899M |
| June 30, 2021 | 4.257M |
| March 31, 2021 | 3.831M |
| December 31, 2020 | 7.894M |
| September 30, 2020 | 9.825M |
| June 30, 2020 | 6.534M |
| Date | Value |
|---|---|
| March 31, 2020 | 6.225M |
| December 31, 2019 | 2.173M |
| September 30, 2019 | 0.261M |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 0.345M |
| September 30, 2017 | 0.295M |
| June 30, 2017 | 0.145M |
| March 31, 2017 | 0.02M |
| December 31, 2016 | 0.52M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.261M
Minimum
Sep 2019
29.89M
Maximum
Mar 2022
9.717M
Average
5.241M
Median
Revenue (TTM) Benchmarks
| Cassava Sciences Inc | -- |
| Heron Therapeutics Inc | 127.04M |
| Actinium Pharmaceuticals Inc | -- |
| Karyopharm Therapeutics Inc | 146.03M |
| Ocular Therapeutix Inc | 58.44M |